Digital Health
FDA & Cerner Enviza Collaborate to Develop AI Tools for Drug Safety
What You Should Know: – Cerner Enviza, an Oracle company, and FDA’s Sentinel Innovation Center are teaming up to develop AI tools to extract and assess…
What You Should Know:
– Cerner Enviza, an Oracle company, and FDA’s Sentinel Innovation Center are teaming up to develop AI tools to extract and assess clinical notes to better understand drug safety.
– Teaming with John Snow Labs, Cerner Enviza will use AI and NLP to develop tools to extract information from clinical notes within the EHR to better aid in better understanding the effects of medicines on large populations. The project known as the Multi-source Observational Safety Study for Advanced Information Classification Using NLP (MOSAIC-NLP) is also supported by the participation of Children’s Hospital of Orange County, National Jewish Health, and Kaiser Permanente Washington Health Research Institute will provide clinical expertise and consulting.
– Focusing on the asthma drug, montelukast, and its possibility of mental health side effects, this two-year project will demonstrate how the use of machine learning and NLP technology with unstructured data may help fill gaps in knowledge.
Keep it Short
By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
Seattle startup Olamedi building platform to automate health clinic communications
A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…
